Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The ENCalmSocial Trial: A Randomized, Double-Blind, Placebo-Controlled Monotherapy Trial to Evaluate the Efficacy and Safety of ENX-102 in Participants With Social Anxiety Disorder

NCT07193563 is registered in ClinicalTrials.gov with Engrail Therapeutics INC as lead sponsor.

NCT NCT07193563
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07193563 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The ENCalmSocial Trial: A Randomized, Double-Blind, Placebo-Controlled Monotherapy Trial to Evaluate the Efficacy and Safety of ENX-102 in Participants With Social Anxiety Disorder
Lead sponsor
Engrail Therapeutics INC
Phase
Phase 2
Overall status
Completed
Start date
September 5, 2025
Completion date
March 19, 2026
Enrollment
47 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

social anxiety disorder (sad)